SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer

NCT03732508 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Esophageal Squamous Cell Cancer

Interventions

DRUG: Irinotecan liposome
DRUG: SHR-1316
DRUG: Fluorouracil

Sponsor

Jiangsu HengRui Medicine Co., Ltd.